Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Fibroblast Growth Factor 23 and Inflammation in CKD

Open access
Munoz Mendoza, Jair, Isakova, Tamara, Ricardo, Ana C., Xie, Huiliang, Navaneethan, Sankar D., Anderson, Amanda H., Bazzano, Lydia A., Xie, Dawei, Kretzler, Matthias, Nessel, Lisa, Hamm, L. Lee, Negrea, Lavinia, Leonard, Mary B., Raj, Dominic, Wolf, Myles·2012·Clinical Journal of the American Society of Nephrology

Abstract

Summary: Background and objectives: Levels of fibroblast growth factor 23 (FGF23) and inflammatory markers are commonly elevated in CKD, and each is associated with adverse clinical outcomes. This study tested the hypothesis that FGF23 is independently associated with inflammation in CKD. Design, setting, participants, & measurements: The association between levels of FGF23 and the inflammatory markers IL-6, C-reactive protein (CRP), TNF-α, and fibrinogen was assessed in a cross-sectional analysis of 3879 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study between June 2003 and September 2008. Results: FGF23 correlated directly with IL-6 ( r =0.4), CRP ( r =0.2), TNF-α ( r =0.4), and fibrinogen ( r =0.3; P <0.001 for each). In univariate and multivariable-adjusted linear regression analyses, natural log (ln) transformed FGF23 was significantly associated with lnIL-6, lnCRP, lnTNF-α, and fibrinogen ( P <0.001 for each). Each unit higher lnFGF23 was associated with severe inflammation, defined as levels of all inflammatory markers in the highest 25th percentile, in univariate (odds ratio [OR], 2.4 [95% confidence interval (CI), 2.0–2.9]) and multivariable-adjusted (OR, 2.0 [95% CI, 1.6–2.5]) logistic regression analyses. Ascending FGF23 quartiles were independently associated with severe inflammation (OR, 5.6 for the highest versus lowest FGF23 quartile [95% CI, 2.3–13.9]; P for trend < 0.001). Conclusions: Higher FGF23 levels are independently associated with higher levels of inflammatory markers in patients with CKD and with significantly greater odds of severe inflammation. Future studies should evaluate whether inflammation modifies the association between FGF23 and adverse outcomes in CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.13281211

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 267

Metadata

Authors
Munoz Mendoza, J., Isakova, T., Ricardo, A. C., Xie, H., Navaneethan, S. D., Anderson, A. H., Bazzano, L. A., Xie, D., Kretzler, M., Nessel, L., Hamm, L. L., Negrea, L., Leonard, M. B., Raj, D., & Wolf, M.
Venue
Clinical Journal of the American Society of Nephrology
Published
2012-07
Volume
7
Issue
7
Pages
1155-1162
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2121435915
Cited by
267
References
5
FWCI
14.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibroblast Growth Factor 23 and Inflammation in CKD. https://app.cochat.ai/papers/10.2215/cjn.13281211
The paper
Munoz Mendoza, J., Isakova, T., Ricardo, A. C., Xie, H., Navaneethan, S. D., Anderson, A. H., Bazzano, L. A., Xie, D., Kretzler, M., Nessel, L., Hamm, L. L., Negrea, L., Leonard, M. B., Raj, D., & Wolf, M. (2012). Fibroblast Growth Factor 23 and Inflammation in CKD. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.13281211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.